DexCom Inc
DXCM: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| SHk | LOCK|n^$&H | LOCK|@%zB!JlD |
Dexcom Earnings: Near-Term Turbulence, but Stability Should Emerge in 2025
Dexcom posted another disappointing set of results for its third quarter, featuring anemic 2% reported revenue growth, as it seeks to commercialize its new Stelo product and navigate distribution channels.
